TYDENE LIMITED

Here is a comprehensive financial health assessment for TYDENE LIMITED, applying a diagnostic approach to evaluate the company's financial wellness.

1. Financial Health Score: A-

Explanation: The company exhibits a strong and robust constitution. It has demonstrated consistent revenue growth and steady accumulation of equity over the past five years. While its profit margins are inherently thin—a common genetic trait in the wholesale distribution sector—it has effectively managed its costs and liabilities. The slight deduction in grade is due to historically tight cash reserves in certain years, though the latest financial year shows a very healthy improvement in cash flow.

2. Key Vital Signs

• Heart Rate (Revenue Growth): Strong and steady. Turnover has grown from £30.3m in 2022 to £46.6m in 2026. This shows a vigorous pulse, indicating strong market demand and effective sales strategies.
• Blood Pressure (Liquidity & Cash Flow): Stabilizing. In 2025, cash on hand was a concerning £67,121. However, by 2026, cash reserves surged to £452,501. While the company operates with tight working capital, its latest blood pressure reading is within a healthy range.
• Cholesterol Levels (Debt to Equity Ratio): Healthy. With total liabilities of £3.18m against net assets (shareholders' funds) of £4.77m, the company has a conservative debt-to-equity ratio of approximately 0.66. There is no dangerous buildup of "bad cholesterol" (excessive debt) blocking the arteries of the business.
• Muscle Mass (Net Assets): Growing stronger. Net assets have increased consistently from £2.9m in 2021 to £4.77m in 2026. The business is successfully retaining earnings and building its financial muscle.

3. Diagnosis

Symptoms Analysis: The patient is a medium-sized wholesale distributor of beverages operating in a highly competitive, low-margin environment. The thin gross profit margins (around 7%) and net profit margins (around 1.8%) are chronic industry conditions, not acute illnesses. The company manages this through strict overhead control and a high-volume turnover model.

The strategic report reveals a smart operational tactic: maintaining very low stock levels due to the perishable nature of the goods, relying instead on consignment purchases and multiple suppliers. This keeps storage costs down but requires excellent supplier relationships and reliable logistics.

Prognosis: The future outlook is positive. The company has proven its resilience through significant revenue growth over the past five years. The director's expectation of continued growth through exploring new products and customers is a sound prescription for future health, provided the tight margin discipline is maintained.

4. Recommendations

• Build a Cash Emergency Fund: While cash flow improved dramatically in 2026, the historical volatility (dropping to as low as £31k in 2022) suggests the company should intentionally maintain a larger cash buffer to weather any sudden supply chain disruptions or customer payment delays.
• Continuous Supplier Diversification: The business relies heavily on consignment purchases, which require insurance cover based on financial health. Continue the excellent practice of maintaining multiple suppliers per product to prevent "stock-outs" that could damage the company's reputation.
• Monitor Margin Erosion: In a high-inflation environment, input costs can rise quickly. The company should continuously review pricing strategies with customers to ensure that the thin margins are protected against sudden cost increases from suppliers.